UNSPSC 51391723: Levalbuterol or levosalbutamol

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51391723

Definition

This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C13H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EDN2NBH5SS, chemically known as 1,3-benzenedimethanol, alpha(sup 1)-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, (-)- but generally known as levalbuterol, which bears US NIH Compound Identifier 123600. European Medicines Agency schedules Levosalbutamol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08491MIG.

The term LEVOSALBUTAMOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). Levalbuterol or levosalbutamol bears US NLM identifiers UMLS ID C0772501 and NCI Concept Code C74196. SMILES: CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.

About UNSPSC 51391723

UNSPSC 51391723 Levalbuterol or levosalbutamol is a Commodity code that captures pharmaceutical emergency-response medications and related medical consumables procured by state and local health authorities. Recent solicitation activity shows state and local buyers using this code to source naloxone (an opioid-overdose reversal agent) and drug deactivation systems for community health programs, though the code's nominal scope and the actual procurement may diverge. Seminole County, Florida—a representative issuing body under this code—recently sought to procure naloxone and drug deactivation systems through competitive bidding to support public health initiatives. County health departments and special-purpose health districts appear to be the primary issuing bodies under this code, though the recent-opportunities block contains only one solicitation and does not establish a broader pattern of repeat buyers or geographic concentration.

Seminole County, Florida represents the only recent activity in the source data. The county posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building in Sanford, with quarterly delivery required. The IFB closed on July 26, 2023 (a past date relative to the current posting). Vendors were required to submit bids electronically through the county's e-Procurement Portal and comply with E-Verify employment verification, drug-free workplace certification, and federal compliance obligations tied to potential FEMA funding. The contract structure included a two-year initial term with an optional one-year renewal and a three-month probationary period at the county's discretion. Beyond this single opportunity, the source provides no evidence of recent activity under this code in other states or jurisdictions.

Quick answers

What is UNSPSC 51391723?

UNSPSC 51391723 is Levalbuterol or levosalbutamol, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51391723?

UNSPSC 51391723 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51391723

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code